Literature DB >> 7040116

The menopause: benefits and risks of estrogen-progestogen replacement therapy.

R D Gambrell.   

Abstract

Keywords:  Biology; Blood Coagulation Effects; Breast Cancer; Cancer; Cardiovascular Effects; Diseases; Endocrine System; Endometrial Cancer; Estrogens--beneficial effects; Estrogens--contraindications; Estrogens--indications; Gallbladder Diseases; Hormones; Lipid Metabolic Effects; Menopause; Neoplasms; Physiology; Progestational Hormones; Progesterone--beneficial effects; Progesterone--contraindications; Progesterone--indications; Psychological Factors; Reproduction; Treatment

Mesh：

Substances：

Year:  1982        PMID： 7040116     DOI： 10.1016/s0015-0282(16)46149-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  18 in total

1.  Value of Dundee coronary risk-disk.

Authors:  A S Dixon
Journal:  BMJ       Date:  1992-08-22

Review 2.  Selective drug delivery to bone using acidic oligopeptides.

Authors:  Junko Ishizaki; Yoshihiro Waki; Tatsuo Takahashi-Nishioka; Koichi Yokogawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

3.  Obstetrics and gynecology-important advances in clinical medicine: comparative risks of osteoporosis and endometrial cancer.

Authors:  B J Davidson
Journal:  West J Med       Date:  1983-10

4.  Osteoporosis: Part II. Prevention of Bone Loss and Fractures in Women and Risks of Menopausal Estrogen Therapy.

Authors: 
Journal:  West J Med       Date:  1983-08

5.  Estrogen replacement therapy.

Authors:  J R Higgin
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

6.  Are women using postmenopausal estrogens? A community survey.

Authors:  R B Harris; A Laws; V M Reddy; A King; W L Haskell
Journal:  Am J Public Health       Date:  1990-10       Impact factor: 9.308

Review 7.  Exercise and bone mineral density.

Authors:  P D Chilibeck; D G Sale; C E Webber
Journal:  Sports Med       Date:  1995-02       Impact factor: 11.136

8.  Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women.

Authors:  M Gambacciani; A Spinetti; B Cappagli; F Taponeco; R Felipetto; D Parrini; N Cappelli; P Fioretti
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

9.  Pharmacokinetics of estradiol valerate 2mg + dienogest 2mg (climodien® 2/2) after single and repeated oral administration in healthy postmenopausal women.

Authors:  H Zimmerman; J J Thebault; T Duvauchelle; A Mignot; A Renoux; V Gualano
Journal:  Clin Drug Investig       Date:  2000       Impact factor: 2.859

Review 10.  Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents.

Authors:  Hideki Hirabayashi; Jiro Fujisaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.